obio 4/21/17 obio 4/21/17

CAAP Company: Swift Medical Closes Over Subscribed Funding Round

OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner.

obio 4/20/17 obio 4/20/17

OBIO + JLABS Team Up for You

OBIO has partnered with JLABS Toronto to provide access to all JLABS Toronto Events for OBIO Members for FREE!

obio 4/19/17 obio 4/19/17

MaRS Innovation and KHIDI Commence Joint Research Initiatives

MaRS Innovation (MI) and its South Korean partner, Korea Health Industry Development Institute (KHIDI), continue to build on the five-year global partnership agreement signed in December 2016 during Premier Wynne’s mission to the Republic of Korea.

obio 4/18/17 obio 4/18/17

OBIO CAAP Company: Intronix Technologies Launches Myoguide DOC

OBIO CAAP 2014 company, Intronix Technologies, will be launching their "Myoguide DOC"

obio 4/18/17 obio 4/18/17

Steadiwear Wins Again!

OBIO Member company, Steadiwear, wins again!

obio 4/11/17 obio 4/11/17

CAAP Companies: Eve Medical & QoC Health in The Globe and Mail

Former OBIO CAAP companies, Eve Medical and QoC Health, have been quoted in The Globe and Mail this week

obio 4/11/17 obio 4/11/17

OBIO Member: CCAB Signs Agreement with Pionyr Immunotherapeutics Inc.

OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB)has signed an Agreement with Pionyr Immunotherapeutics Inc.

obio 4/11/17 obio 4/11/17

OBIO Member: Steadiwear Wins RESI on MaRS Innovation Challenge

OBIO Member, Steadiwear, has won 1st Place in the RESI on MaRS Innovation Challenge.

obio 4/11/17 obio 4/11/17

CAAP Companies: Pathcore & WinterLight Labs Announced as HTF Recipients

OBIO CAAP companies, Pathcore and WinterLight Labs have both been announced as recipients of the Ontario Health Technology Fund!

obio 4/4/17 obio 4/4/17

OBIO CAAP® 2017 Kicks Off Just As Toronto Health Innovation Week Launches

OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches.

obio 4/4/17 obio 4/4/17

Call for Proposals: Hamilton Health Sciences & IBM

Hamilton Health Sciences and IBM are seeking proposals for exciting, innovative new projects aimed at improving the delivery of health care.

obio 4/4/17 obio 4/4/17

Pre-CAAP Company: MedStack Turns 2

OBIO Pre-CAAP company, MedStack, has turned 2!

obio 4/4/17 obio 4/4/17

CAAP Company: QoC Health Receives HTF from Province

OBIO CAAP 2016 company, QoC Health, with SMArTVIEW has been selected for one of 15 Ontario Health Technology Grants (HTF).

obio 3/28/17 obio 3/28/17

OBIO Partner: StarFish Medical Acquires Kangaroo Design

OBIO Partner, StarFish Medical has acquired Kangaroo Design of Toronto, the leading medical device development company in Ontario.

obio 3/21/17 obio 3/21/17

OBIO Member: CCAB Innovative Collaboration Accelerating Cancer Treatments

OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB) and OBIO Partner, the National Research Council of Canada (NRC) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).